Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Welch

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of the Endocrine Society|September 16, 2022
Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin ReceptorsAkua Graf, James Welch, Rashika Bansal, et al.
The New England Journal of Medicine|November 17, 2021
Parathyroid Hormone Resistance and Autoantibodies to the PTH1 ReceptorAdel Mandl, Peter D Burbelo, Giovanni Di Pasquale, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
IEEE Open Journal of Engineering in Medicine and Biology|June 30, 2021
Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?Catherine P Adans-Dester, Stacy Bamberg, Francesco P Bertacchi, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of the Endocrine Society|September 16, 2022
Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin ReceptorsAkua Graf, James Welch, Rashika Bansal, et al.
The New England Journal of Medicine|November 17, 2021
Parathyroid Hormone Resistance and Autoantibodies to the PTH1 ReceptorAdel Mandl, Peter D Burbelo, Giovanni Di Pasquale, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
IEEE Open Journal of Engineering in Medicine and Biology|June 30, 2021
Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?Catherine P Adans-Dester, Stacy Bamberg, Francesco P Bertacchi, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 4